Biobanking in Africa: Opportunities and Challenges

  • Jim VaughtEmail author


Biobanking and its associated policies and procedures for managing biological specimen collections are critical to the success of a variety of research endeavors. Several international organizations have produced best practices which cover the important technical and ethical-regulatory issues that are important for the collection and management of biospecimens and associated data. The expanding and global nature of biomedical research has resulted in disparities in biobanking practices among high-income countries (HIC) and low- and middle-income countries (LMIC). In Africa, projects such as H3Africa and B3Africa have resulted in new and promising advances in biobanking infrastructure and the creation of biobanking networks. However, the initiation of such projects has highlighted some of the challenges faced by biobanks in Africa, from both the technical and ethical-regulatory perspectives.


Biobanking Africa Low and middle income countries H3 Africa B3 Africa Sustainability 


  1. 1.
    Armed Forces Institute of Pathology. Accessed 20 Apr 2016
  2. 2.
    Doll R, Smith PG (1982) Comparison between registries: age-standardized rates. In: JAH W, Muir CS (eds) Cancer incidence in five continents, vol IV. IARC Scientific Publication No. 42, Lyon, pp 671–675Google Scholar
  3. 3.
    Vaught J (2016) Biobanking comes of age: the transition to biospecimens science. Annu Rev Pharmacol Toxicol 56:211–228CrossRefPubMedGoogle Scholar
  4. 4.
    Hewitt SM, Badve SS, True LD (2012) Impact of preanalytic factors on the design and application of integral biomarkers for directing patient therapy. Clin Cancer Res 18:1524–1530CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Vaught J (2015) Developments in biospecimen research. Br Med Bull 2015:1–10Google Scholar
  6. 6.
    Moore HM, Compton CC, Alper J, Vaught JB (2011) International approaches to advancing biospecimen science. Cancer Epidemiol Biomark Prev 20:729–732CrossRefGoogle Scholar
  7. 7.
    International Society for Biological and Environmental Repositories (ISBER). [Accessed 20 April 2016]. ISBER Strategic Plan 2014–2017. Accessed 20 Apr 2016
  8. 8.
    European, Middle Eastern and African Society for Biopreservation and Biobanking (ESBB). Accessed 20 Apr 2016
  9. 9.
    BBMRI-ERIC. Accessed 20 Apr 2016
  10. 10.
    BCNet, The Low- and Middle-Income Countries (LMICs) Biobank and Cohort Building Network. Accessed 20 Apr 2016
  11. 11.
    Catholic University Lyon, Masters Program in Biobank Management. Accessed 20 April 2016
  12. 12.
    Vaught J, Bledsoe M, Watson P (2014) Biobanking on multiple continents: will international coordination follow? Biopreserv Biobank 12:1–2CrossRefPubMedGoogle Scholar
  13. 13.
    Vaught J, Abayomi A, Peakman T et al (2014) Critical issues in international biobanking. Clin Chem 60:1368–1374CrossRefPubMedGoogle Scholar
  14. 14.
    Vaught J, Rogers J, Carolin T, Compton C (2011) Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr:24–31Google Scholar
  15. 15.
    Engel KB, Vaught J, Moore HM (2014) National cancer institute biospecimen evidence-based practices: a novel approach to pre-analytical standardization. Biopreserv Biobank 12:148–150CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Vaught JB, Lockhart N, Thiel KS, Schneider JA (2007) Ethical, legal, and policy issues: dominating the biospecimen discussion. Cancer Epidemiol Biomark Prev 16:2521–2523CrossRefGoogle Scholar
  17. 17.
    Forsberg JS, Hansson MG, Eriksson S (2009) Changing perspectives in biobank research: from individual rights to concerns about public health regarding the return of results. Eur J Hum Genet 17:1544–1549CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Office of Human Research Protections (OHRP, US Dept of Health and Human Services). OHRP Basic Elements of Informed Consent. Accessed 20 Apr 2016
  19. 19.
    European Data Protection Reform. Accessed 20 Apr 2016
  20. 20.
    International Agency for Research on Cancer. Common Minimum Technical Standards and Protocols for Biological Resource Centres dedicated to Cancer Research. Accessed 20 Apr 2016
  21. 21.
    Vaught J, Lockhart NC (2012) The evolution of biobanking best practices. Clinica Chim Acta 413:1569–1575CrossRefGoogle Scholar
  22. 22.
    Vaught JB, Caboux E, Hainaut P (2010) International efforts to develop biospecimen best practices. Cancer Epidemiol Biomark Prev 19:912–915CrossRefGoogle Scholar
  23. 23.
    U.S. National Cancer Institute Best Practices for Biological Resources. Accessed 20 Apr 2016
  24. 24.
    Rebbeck T (Ed) 2013 Handbook for Cancer Research in Africa. WHO Regional Office for AfricaGoogle Scholar
  25. 25.
    Vaught J (2013) Economics: the neglected “omics” of biobanking. Biopreserv Biobank 11:259CrossRefPubMedGoogle Scholar
  26. 26.
    Henderson M, Simeon-Dubach D, Albert M (2015) Finding the path to biobank sustainability through sound business planning. Biopreserv Biobank 13:385–386CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Mendy M, Caboux E, Sylla B, Dillner J, Chinquee J, Wild C (2014) BCNet survey participants. Infrastructure and facilities for human biobanking in low- and middle-income countries: a situation analysis. Pathobiology 81:252–260. doi: 10.1159/000362093 CrossRefPubMedGoogle Scholar
  28. 28.
    The Gambia West Africa Medical Research Council Unit. Accessed 20 Apr 2016
  29. 29.
    Sirugo G, van der Loeff M S, Sam O, Nyan O, Pinder M, Hill AV, Kwiatkowski D, Prentice A, de Toma C, Cann HM, Diatta M, Jallow M, Morgan G, Clarke M, Corrah T, Whittle H, McAdam K (2004 Aug) A national DNA bank in the Gambia, West Africa, and genomic research in developing countries. Nat Genet 36(8):785–786CrossRefPubMedGoogle Scholar
  30. 30.
    Human Health and Heredity in Africa (H3Africa). Accessed 20 Apr 2016
  31. 31.
    Abayomi A, Christoffels A, Grewal R et al (2013) Challenges of biobanking in South Africa to facilitate indigenous research in an environment burdened with human immunodeficiency virus, tuberculosis, and emerging noncommunicable diseases. Biopreserv Biobank 11:347–354CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    BBMRI-ERIC B3Africa. Accessed 20 Apr 2016
  33. 33.
    Boyle P, Sullivan R, Zielinski C, Brawley O, Editors. The State of Oncology 2013. International Prevention Research Institute 2013Google Scholar
  34. 34.
    Fleming K (2013) Lack of pathology in lower income countries. In: Boyle P, Sullivan R, Zielinski C, Brawley OW (eds) State of oncology. iPRI, Lyon, FranceGoogle Scholar
  35. 35.
    Pasterk M, Zatloukal K (2013) Biobanks: central importance and standards. In: Boyle P, Sullivan R, Zielinski C, Brawley OW (eds) State of oncology. iPRI, Lyon, FranceGoogle Scholar
  36. 36.
    European Prospective Investigation into Cancer and Nutrition (EPIC). Accessed 20 Apr 2016
  37. 37.
    BBMRI-ESBB HandsOnBiobank. Accessed 20 Apr 2016

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Senior Research Fellow, International Prevention Research Institute (IPRI), Past-President, International Society for Biological and Environmental RepositoriesKensingtonUSA

Personalised recommendations